Animal Antibiotics & Antimicrobials Market by Product (Antibiotics, Antimicrobial), Mode of Delivery (Injections, Oral), Form, Type of Animal - Global Forecast 2024-2030

Animal Antibiotics & Antimicrobials Market by Product (Antibiotics, Antimicrobial), Mode of Delivery (Injections, Oral), Form, Type of Animal - Global Forecast 2024-2030

The Animal Antibiotics & Antimicrobials Market size was estimated at USD 635.51 million in 2023 and expected to reach USD 667.23 million in 2024, at a CAGR 5.25% to reach USD 909.84 million by 2030.

Animal antibiotics & antimicrobials include substances used to treat and prevent bacterial infections in animals, promoting their health and welfare. The rising global demand for animal protein, driven by changing dietary patterns, is driving the market. The intensification of animal farming and increased awareness of the importance of preventing diseases in livestock contribute to the growing usage of antibiotics. Additionally, advancements in veterinary healthcare and a focus on improving overall animal productivity further propel the demand for antibiotics & antimicrobials in the animal health sector. Concerns over antimicrobial resistance (AMR) pose a significant challenge, as the overuse of antibiotics can lead to the development of resistant strains of bacteria. Regulatory restrictions and a push towards more sustainable farming practices contribute to the restraint on the use of certain antibiotics in animal agriculture. The growing trend toward the development of alternatives to traditional antibiotics, such as probiotics and phytogenics, presents an opportunity for innovation in the animal health sector. Furthermore, increased focus on preventive measures, such as vaccines and biosecurity practices, offers opportunities for sustainable growth in the animal antibiotics & antimicrobials market.

Regional Insights

In the Americas, the market for animal antibiotics & antimicrobials is driven by the significant presence of intensive animal farming practices and a growing emphasis on animal welfare. The rising demand for animal-derived products, coupled with increased awareness of disease prevention in livestock, contributes to the widespread use of antibiotics in the region. Advanced veterinary healthcare infrastructure and stringent regulations further shape the landscape, with North and South American countries actively contributing to the expansion of the animal antibiotics & antimicrobials market. In the Asia-Pacific region, the animal antibiotics & antimicrobials market experiences substantial growth due to the increasing demand for animal protein, particularly in countries including China and India. The expansion of the livestock industry, coupled with a rising focus on improving animal health and productivity, drives the adoption of antibiotics in the region. Within the EMEA region, the market for animal antibiotics & antimicrobials is influenced by stringent regulations on antibiotic use in livestock, particularly in European countries. The emphasis on sustainable farming practices and heightened concerns about antimicrobial resistance contribute to shaping the market dynamics. Additionally, the Middle East and Africa witness growth in animal farming activities, driven by increasing urbanization and dietary changes. The EMEA region plays a pivotal role in steering the global direction of responsible and effective use of animal antibiotics & antimicrobials.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Animal Antibiotics & Antimicrobials Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Rising demand for livestock products and strong demand for penicillin based antibiotics
• Increasing government involvement in countering animal diseases outbreaks
• Growing huge capital investment for the development of drugs for animal diseases

Market Restraints

• Concerns regarding resistance to antibiotic stringent regulatory approvals

Market Opportunities

• Accelerating advanced research and development facilities, and new drug development activities
• Growing focus towards sustainability of new antimicrobials

Market Challenges

• Availability of substitutes

Market Segmentation Analysis

• Product: Growing need for antibiotics for disease prevention and treatment
• Mode of Delivery: Rising inclination towards oral administration as it’s a non-invasive procedure
• Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
• Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Animal Antibiotics & Antimicrobials Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Animal Antibiotics & Antimicrobials Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Zoetis Demonstrates Canine Innovation with Commercial Launch of Librela (bedinvetmab injection) in the U.S.

Zoetis launched Librela in the United States, showcasing our pioneering efforts in canine health innovation and commitment to personalized care. Librela, an FDA-approved monthly injectable monoclonal antibody, effectively controls pain associated with osteoarthritis in dogs. Veterinarians aims to enhance the overall health and well-being of dogs, while fostering stronger bonds between pet owners and their beloved companions.

Huvepharma Returns The Only FDA-Approved Triple-Sulfa Medication To US Market

Huvepharma, Inc. relaunched PoultrySulfa, the only FDA-approved triple-sulfa veterinary product available in the US. PoultrySulfa is a water-soluble antibiotic powder used to control coccidiosis and fowl cholera in chickens and turkeys when caused by susceptible pathogens. It provides a wider margin of safety compared to traditional single-sulfa products and offers efficient delivery through animals' drinking water. The product is conveniently packaged in pre-measured, individually sealed packets for simple and accurate dosing.

Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology

Elanco Animal Health Inc. and Ginkgo Bioworks partnered to establish BiomEdit, a dedicated company that aims to discover and introduce innovative probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health. Through leveraging breakthroughs in the rapidly growing field of microbiome science, this new venture will primarily focus on developing products that address various needs in medicated feed ingredients, nutritional health, therapeutics for livestock and pet species, as well as biosecurity technology for animal disease monitoring. The goal of BiomEdit is to provide effective solutions for animal health, considering the importance of both animal welfare and public health.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Animal Antibiotics & Antimicrobials Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibiotics & Antimicrobials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
• Antibiotics
• Antimicrobial
• Mode of Delivery
• Injections
• Oral
• Form
• Powders & Tablets
• Solutions
• Type of Animal
• Companion Animals
• Cats
• Dogs
• Horses
• Food-Producing Animals
• Cattle
• Pigs
• Poultry
• Sheep & Goats

Region

Americas

Argentina

Brazil

Canada

Mexico

United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific

Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa

Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year